Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
365.00    20.00 (5.80%)
Bid:
350.00
Ask:
380.00
Spread: 30.00 (8.571%)
Market Cap: £34.88m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

Directorate Changes

22 Jul 2024 09:43

RNS Number : 2809X
Cropper(James) PLC
22 July 2024
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT CONSTITUTES INSIDE INFORMATION AS STIPULATED UNDER THE UK'S MARKET ABUSE REGULATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, SUCH INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

22 July 2024

 

 

James Cropper plc

('James Cropper', the 'Company' or the 'Group')

 

Directorate Changes

 

James Cropper plc (AIM: CRPR), the Advanced Materials and Paper & Packaging group, announces that Jon Yeung will be appointed as an independent Non-Executive Director and join the Board following conclusion of the Company's AGM expected to take place in September 2024 ("AGM").

 

Jon is a chartered accountant and brings significant experience in creating shareholder value through long-term business transformation and growth. During 11 years at LGC Science Group - a global life sciences group serving a variety of end markets globally - Jon held various leadership roles, including Group Finance Director and COO/Managing Director of the £400m Standards division, during which the business saw significant growth. Prior to this Jon spent 16 years at PricewaterhouseCoopers LLP working extensively with listed businesses across audit and transaction projects including financing and M&A. Jon is currently a Non-Executive Director and Audit Committee Chair at private equity owned Fera Science. He also serves as an advisory Board member for Charterpath, a not-for-profit organisation which seeks to connect individuals with finance skills with charities.

 

Upon joining the Board, Jon will be appointed as Audit Committee Chair and will serve as a member of the Remuneration and Nomination Committees.

 

The Board also announces that Jim Sharp will stand down as a Non-Executive Director and from the Board upon conclusion of the Company's forthcoming AGM after 15 years' service.

 

Further information relating to Jon Yeung in accordance with Rule 17 and paragraph (g) of Schedule Two of the AIM Rules for Companies is set out at the end of this announcement.

 

Mark Cropper, Non-Executive Chair, commented:

 

"On behalf of the Board, I am delighted to welcome Jon to James Cropper. Jon's depth of finance, leadership and business growth experience will be hugely beneficial to the Board as we seek breakout growth in the coming years, and I look forward to working with him.

 

"I would also like to thank Jim for his unwavering support and commitment to James Cropper over the last 15 years. Jim has made a very significant contribution during his tenure, and he steps down from the Board with our sincerest gratitude."

 

 

-ENDS-

 

Enquiries:

 

James Cropper plc Mark Cropper, Non-Executive Chair

+44(0)1539 722002

 

Shore Capital - (Nominated Adviser and Broker)

Daniel Bush, David Coaten, Henry Willcocks, Lucy Bowden

Tel: +44 (0)207 408 4090

 

Burson Buchanan - Financial PR

Chris Lane, Charles Ryland, Jamie Hooper, Verity Parker

jamescropper@buchanancomms.co.uk

Tel: +44 (0) 207 466 5000

 

Regulatory Disclosures:

 

Save for the information set out herein, there are no further disclosures to be made in accordance with Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in respect of the appointment of Jonathan Mark Yeung (aged 51).

 

Current Directorships and Partnerships

Cricket Dorset Limited

Fera Science Limited

Hazel II Topco Limited

LGC Science and Standards (India) Private Limited

 

Past Directorships and Partnerships

9123725 Canada Inc.

Innovaspeak Limited

M.B.H. Analytical Limited

Paragon Scientific Limited

Techno-Path Manufacturing Limited

 

Notes for editors:

 

James Cropper is a market leader in Advanced Materials and Paper & Packaging, centred around four market audiences: Energy Solutions, Composite Solutions, Luxury Packaging and Creative Papers.

 

A purpose-led business, built upon six generations of the Cropper family, James Cropper has a 600+ international workforce and an operational reach in over 50 countries.

 

Established in 1845, the Group manufactures creative papers, luxury packaging and advanced materials incorporating pioneering non-wovens and electrochemical coatings.

 

James Cropper is a specialist provider of niche solutions tailored to a unique customer specification, ranging from substrates and components in hydrogen electrolysis and fuel cells to bespoke colours and textures in paper and moulded fibre packaging designed to replace single use plastics.

 

The Group operates across multiple markets from luxury retail to renewable energy. It is renowned globally for service, capability, pioneering and multi award-winning commitment to the highest standards of sustainability.

 

James Cropper's goal is to be operationally net zero by 2030 and to reduce carbon through its entire supply chain to net zero by 2050.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUPCMUPCURP
Date   Source Headline
8th Sep 201412:53 pmRNSExpansion of production capacity
22nd Aug 201410:44 amRNSAcquisition of shares by Share Incentive Plan
5th Aug 20144:51 pmRNSDirector/PDMR Shareholding
30th Jul 201411:00 amRNSAnnual General Meeting and Trading Update
21st Jul 20145:01 pmRNSDIRECTORS' SHAREHOLDINGS
11th Jul 201412:10 pmRNSDirector/PDMR Shareholding
4th Jul 201411:45 amRNSDirector/PDMR Shareholding
24th Jun 20147:00 amRNSFinal Results
5th Jun 20147:00 amRNSBoard changes
2nd Jun 20143:41 pmRNSTotal Voting Rights
6th May 20148:53 amRNSIssue of Equity
1st Apr 20147:00 amRNSIssue of Equity
31st Mar 20144:57 pmRNSTotal Voting Rights
4th Mar 20147:00 amRNSIssue of Equity
3rd Mar 20141:38 pmRNSHolding(s) in Company
28th Feb 201411:40 amRNSBoard Change
12th Feb 201410:42 amRNSIssue of Equity
7th Jan 20144:08 pmRNSHolding(s) in Company
2nd Jan 201410:56 amRNSTotal Voting Rights
2nd Jan 20147:00 amRNSBoard appointment
5th Dec 20139:48 amRNSIssue of Equity
5th Dec 20138:18 amRNSDIRECTORS' SHAREHOLDINGS
27th Nov 20137:00 amRNSIssue of Equity
15th Nov 20139:14 amRNSDirector Dealing
12th Nov 20137:00 amRNSHalf-year results to 28 September 2013
1st Oct 201310:07 amRNSHolding(s) in Company
20th Sep 20134:54 pmRNSDirector Dealing
17th Sep 20133:22 pmRNSDirector Dealing
17th Sep 20137:00 amRNSBoard appointment
7th Aug 201311:36 amRNSDirector Dealing
1st Aug 20137:00 amRNSDIRECTORS' SHAREHOLDINGS
31st Jul 201311:00 amRNSAnnual General Meeting and Trading Update
23rd Jul 20135:18 pmRNSDirector/PDMR Shareholding
17th Jul 20137:00 amRNSNew Recycling Technology Developed
4th Jul 20137:00 amRNSIssue of Equity
25th Jun 20137:00 amRNSPrelim Results for the year ended 30 March 2013
29th May 201311:46 amRNSBoard change
24th May 201311:27 amRNSBoard changes
2nd Apr 201312:42 pmRNSTotal Voting Rights
28th Mar 20137:00 amRNSIssue of Equity
20th Mar 201311:09 amRNSHolding(s) in Company
19th Mar 201311:31 amRNSDirector Shareholding
15th Mar 20137:00 amRNSIssue of Equity
8th Mar 20134:31 pmRNSHolding(s) in Company
5th Mar 20139:09 amRNSTotal Voting Rights
18th Feb 20133:59 pmRNSIssue of Equity
15th Nov 20123:10 pmRNSDirectorship Changes - Replacement
15th Nov 20123:09 pmRNSIssue of Equity & Director Dealing
13th Nov 20127:00 amRNSHalf-year results to 29 September 2012
23rd Oct 20127:00 amRNSRGF support for investment in steam raising plant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.